![]() |
首页 > 美迪医讯 > Carbapenem antimicrobial drugs Report |
Carbapenem antimicrobial drugs Report 【 2008-07-21 发布 】 美迪医讯
Carbapenem antimicrobial drugs ReportResearch Report on Chinese Carbapenem antimicrobial drugs Market
Research Report on Chinese Carbapenem antimicrobial drugs Market
Price: US$1,900
Contact: Mr.Humphrey
Tel.: 86-10-58110925 Fax: 86-10-68588305
E-mail: hhuang@medicexchange.com
The peport presents China's market status and development trend of Carbapenems,a class of beta-lactam antibiotics with broad antibacterial spectrum and strong antibacterial action。The report describes the status and development trend about Research & Development and sales of Carbapenems within global market,the China's current market scale and growth trend of Carbapenems in the next 5 years,comparison of domestic prodcut's market share and import product's。 At last the report summarizes the information of international Research & Development for new Carbapenems,the status of application and approval for Carbapenems reviewed by SFDA。
The data presented in this report can reflect the real market status in China,the China's market scale of Carbapenems grew from 230 million in 2000 to 680 million in 2005。
Table of Contents
Table of Contents
Abstract…………………………………………………………………………………1
Overview of products 3
1 General situation of international market of carbapenem
antibiotics……………………………………………………………………………4
2 Carbapenem drugs market in China 6
2.1 National market scale and growth trend from 2000 to 2005……6
2.2 Shares and variation trend of national carbapenem drugs from
2000 to 2005…………………………………………………………………………9
2.3 Sale volume and growth trend of Imipenem/Cilastatinfrom 2000
to 2005………………………………………………………………………………10
2.4 Sale volume and growth trend of Meropenem from 2000 to
2005……………………………………………………………………………………11
2.5 Sale volume and growth trend of Panipenem/Betamipron from
2000 to 2005…………………………………………………………………………11
2.6 Sales Status of Import and Domestic Carbapenem Drugs…………12
2.7 Evaluation on demand volume of carbapenem Bulk Drugs in the
next 5 years…………………………………………………………………………13
3. Shares of brands…………………………………………………………………15
3.1 Market share variation and advantage appraisal of the 5 brands
from 2000 to 2005…………………………………………………………………15
3.1.1 Market share variation of the 5 brands in recent 5 years…15
3.1.2 Shares of brands in 2005……………………………………………17
3.1.3 Sales Analysis on Different Brand Names of Meropenem from
2000 to 2004…………………………………………………………………………17
3.2 Market Shares of Different Brand Names in Sample Cities in
2005……………………………………………………………………………………19
“Tienam”……………………………………………………………………20
“BeiNeng”……………………………………………………………………21
“Mepem”………………………………………………………………………21
“Carbenin”…………………………………………………………………23
“Hisunpharm MeiTe”………………………………………………………23
3.3 Market Shares of Different Brand Names in Major Cities in
2005……………………………………………………………………………………24
Beijing…………………………………………………………………………24
Shanghai………………………………………………………………………25
Guangzhou………………………………………………………………………26
4. Research and Development of new products………………………………27
4.1 Domestic and imported products on Chinese market………………27
4.2 Imitation and Application Status of Carbapenem Antimicrobial
Drugs in China………………………………………………………………………29
4.2.1 Types of products……………………………………………………29
4.2.2 Application Enterprises……………………………………………31
4.3 Background of other carbapenem drugs about to enter into
Chinese market………………………………………………………………………38
Biapenem………………………………………………………………………38
Ertapenem……………………………………………………………………38
Doripenem……………………………………………………………………39
4.4 Penems products: comparison between Faropenem and
carbapenems…………………………………………………………………………39
4.5 Clinical evaluation of anti-severe infection drugs…………41
4.5.1 Main characters of carbapenem antibiotics…………………41
4.5.2 Clinical evaluation of carbapenems…………………………42
4.6 Products in process of development in the world currently…45
Appendix 1 List of Enterprises Submited Applications for
Carbapenems to SFDA………………………………………………………………47
Appendix 2 Retail Prices of Different Carbapenems with Different
Strengths……………………………………………………………………………59
Tables and Figures
Table 1 Launched Kinds of Carbapenems within the Global Market……4
Table 2 Sales Values of Carbapenems within the Global Market from
2000 to 2004…………………………………………………………………………5
Table 3 Breeds in the Catalogue of Drugs for Basic National Medical
Insurance………………………………………………………………………………6
Table 4 Market Scale of Carbapenems in China from 2000 to 2005……7
Table 5 Sales Scales of Three Carbapenems in 2005………………………9
Table 6 Sales Values of Imipenem/Cilastatin from 2000 to 2005……10
Table 7 Sales Values of Meropenem from 2000 to 2005……………………11
Table 8 Sales Values of Panipenem/Betamipron from 2001 to 2005……11
Table 9 Import Volumes of “TIENAM”(Imipenem/Cilastatin) from 2002
to 2005………………………………………………………………………………12
Table 10 Import Volumes of “Mepem”(Meropenem) from 2002 to first
half of 2005…………………………………………………………………………13
Table 11 Import Volumes of “Carbenin”(
本文关键字:
《美迪医讯》欢迎您参与新闻投稿,业务咨询: 美迪医疗网业务咨询《上海医疗器械批发》产品推荐
|
合作支持:中华医学会 | 中华医院管理学会 | 国家食品药品监督管理家用护理器械商城 | 国药励展展览有限责任公 | 医学装备协会 |
刊登广告 | 友情链接 | 广告代理商加盟 | 关于美迪 | 法律声明 | 隐私保护 | 网站地图 |
把美迪网放进收藏夹 把美迪医疗网介绍给我的朋友 给美迪医疗网留言
美迪医疗网广告业务联系:021-51601230 产品咨询业务联系:021-51601230 传真:021-56532303 ![]() 互联网药品信息服务许可证:(沪)-经营性-2009-0003 中华人民共和国电信与信息服务业务经营许可证:(沪)B2-20090029 ![]() ![]() ![]() 公安备案号 31010602000199 医疗器械经营许可证: 沪静药监械经营许20210003号 第二类医疗器械经营备案凭证: 沪静药监械经营备20220042号 营业执照:统一社会信用代码91310108676284138X互联网药品信息服务资格书:(沪)-非经营性-2023-0081 |